Shire to acquire Dyax for initial $5.9 billion

SHARE Shire to acquire Dyax for initial $5.9 billion

LONDON — The Dublin-based drug maker Shire says it will take over U.S. biotechnology firm Dyax in a deal worth an initial $5.9 billion.

The company said Monday that Shire will pay $37.30 in cash for each Dyax share.

Shire also is pursuing Baxalta, the company spun off by Deerfield-based Baxter International in July. Shire has been an buying spree since its deal with AbbVie fell apart last year.

Dyax shareholders will receive an additional $4 a share if certain performance targets are met, which would increase the overall value of the deal by $646 million.

Based in Burlington, Massachusetts, Dyax is specialized in the development of treatments for HAE, a rare genetic disease that can be life-threatening.

The deal is expected to bolster Shire’s role in the treatment of HAE. Dyax has a number of treatment regiments being tested.

The Latest
David Pecker said under oath that he paid $20,000 for the story and then suppressed it, as he did for other celebrities managed by Emanuel’s brother, Hollywood super-agent Ari Emanuel, Politico reported.
More than 1,300 people have been arrested in connection with the breach in almost all 50 states. That includes Illinois, where at least 49 known residents have faced federal charges for their role.
Construction of roadways and bridges decades ago brought a kind of starkness to residential areas in the south suburb, which is now using public art as part of a plan for beautification.
It remains to be seen if Williams and Odunze will be as good as advertised, but draft analysts were virtually unanimous about the Bears’ draft: They took advantage of a tremendous opportunity. “There was only one rational path for the Beasr to take, and they took it,”
El sexto Festival anual de Michelada regresa al sur de Chicago los días 13 y 14 de julio, con Oakwood Beach como su nueva sede designada.